Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| CORCEPT THERAPEUTICS INC | 130,575 | reported | 07 Feb 2019 | tx 26+562,925−187,350 |
| Equillium, Inc. | 70,000 | reported | 28 May 2026 | tx 23+775,911−278,708 |
| GERON CORP | 51,323 | reported | 29 Mar 2019 | tx 15+539,099 |
| Vivani Medical, Inc. | 47,212 | reported | 01 Jan 2026 | tx 7+216,259−237 |
| NOVACEA INC | 30,000 | reported | 13 Feb 2008 | tx 3+42,500−30,000 |
| ILLUMINA, INC. | 15,924 | reported | 25 May 2017 | tx 401+308,529−355,105 |
| CASTLE BIOSCIENCES INC | 11,766 | reported | 28 May 2026 | tx 489+1,071,629−2,357,848 |
| INTERCEPT PHARMACEUTICALS INC | 0 | reported | 08 Nov 2023 | tx 28+90,017−90,017 |
| BioMed Realty Trust Inc | 0 | reported | 27 Jan 2016 | tx 5+15,469−15,469 |
| Nuvation Bio Inc. | 0 | reported | 10 Feb 2021 | tx 2+25,000−25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | CASTLE BIOSCIENCES INC | 11,766 | 0.00 USD | deriv |
| 28 May 2026 | GRANT_AWARD | Equillium, Inc. | 70,000 | 0.00 USD | deriv |
| 22 May 2026 | EXERCISE | CASTLE BIOSCIENCES INC | 13,667 | — | |
| 22 May 2026 | EXERCISE | CASTLE BIOSCIENCES INC | 13,667 | 0.00 USD | deriv |
| 01 Jan 2026 | GRANT_AWARD | Vivani Medical, Inc. | 47,212 | 1.23 USD | deriv |
| 01 Jan 2025 | OTHER | Vivani Medical, Inc. | 237 | 1.16 USD | deriv |
| 24 Jun 2025 | GRANT_AWARD | Vivani Medical, Inc. | 35,135 | 1.27 USD | deriv |
| 21 May 2025 | EXERCISE | CASTLE BIOSCIENCES INC | 8,673 | — | |
| 21 May 2025 | EXERCISE | CASTLE BIOSCIENCES INC | 8,673 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | CASTLE BIOSCIENCES INC | 13,667 | 0.00 USD | deriv |
| 14 Feb 2025 | OTHER | Equillium, Inc. | 90,000 | — | deriv |
| 14 Feb 2025 | GRANT_AWARD | Equillium, Inc. | 36,000 | — | deriv |
| 14 Feb 2025 | OTHER | Equillium, Inc. | 36,000 | — | deriv |
| 14 Feb 2025 | GRANT_AWARD | Equillium, Inc. | 28,708 | — | deriv |
| 14 Feb 2025 | OTHER | Equillium, Inc. | 28,708 | — | deriv |
| 14 Feb 2025 | OTHER | Equillium, Inc. | 36,000 | — | deriv |
| 14 Feb 2025 | GRANT_AWARD | Equillium, Inc. | 38,000 | — | deriv |
| 14 Feb 2025 | OTHER | Equillium, Inc. | 38,000 | — | deriv |
| 14 Feb 2025 | GRANT_AWARD | Equillium, Inc. | 50,000 | — | deriv |
| 14 Feb 2025 | OTHER | Equillium, Inc. | 50,000 | — | deriv |
| 14 Feb 2025 | GRANT_AWARD | Equillium, Inc. | 90,000 | — | deriv |
| 14 Feb 2025 | GRANT_AWARD | Equillium, Inc. | 36,000 | — | deriv |
| 05 Feb 2025 | SALE | CASTLE BIOSCIENCES INC | 5,017 | 28.17 USD | |
| 05 Feb 2025 | SALE | CASTLE BIOSCIENCES INC | 1,425 | 28.17 USD | |
| 05 Feb 2025 | SALE | CASTLE BIOSCIENCES INC | 1,425 | 28.17 USD |
2 purchases reported after at least 12 months of silence — most recent on 09 Apr 2018.